Note: Turning Point Therapeutics's revenues are gauged from an analysis of company filings.
Turning Point Therapeutics's Income Statement (based on Industry Averages)
Turning Point Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Turning Point Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
October 30, 2018
16
100%
$80 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Turning Point Therapeutics is developing and marketing.
Turning Point Therapeutics doesn't have any recent trademark applications, indicating Turning Point Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
POWTYROS Pharmaceutical preparations for the treatment of cancer
09/12/2022
REPKY Pharmaceutical preparations for the treatment of cancer
02/17/2022
AUGTYRO Pharmaceutical preparations for the treatment of cancer
02/17/2022
See all trademarks and details in the Full Report.
Market Share of Turning Point Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Turning Point Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Turning Point Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Turning Point Therapeutics's Fastest Growing Competitors
These companies are in the same general field as Turning Point Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
